Friday, 6 November 2026LatestVideosAboutContact
Latest
Mbappe's Mao remarks controversy: Real Madrid, LaLiga face pressure despite apologyCM Revanth to flag off Rs 9,100 cr development works in 3 daysScientists achieve record-breaking low temperature on China's space station, paving the way for new physics experimentsEvolutionary history and genetic basis of spruce diversification revealedGiant exoplanet emerges from the dark when the James Webb Space Telescope turns out the starlightAI is the new dating dealbreakerTata Power commissions 300 MW solar project in Karnataka, to cut 1 lakh tonnes of carbon emissions yearlyTelangana aims to attract 100 new GCCs to Hyderabad in a year: Sridhar BabuCabinet sub-committee pushes land pooling, industrial land auctions to boost revenueOrissa High Court stays Hockey India elections on December 5; Hockey Odisha challenges notice‘Clicky Ponting’ handed two-year suspension for finger-clicking deceptionKhalid Jamil names India squad for upcoming New Zealand friendlies
BusinessUpdated 58 min ago

Generic drugs, implants & injectables being studied: Maharashtra FDA Commissioner

BusinessLine6 November 2026 at 9:38 pm IST
Image: BusinessLine

It was a study of hospital practices that led the Commissioner to flag the huge gap between a manufacturer’s production cost and the MRP on consumables

Continue reading on BusinessLine

Hello Headlines links you to the original publisher for the full story.

Read full story

More in Business

See all

Tata Power commissions 300 MW solar project in Karnataka, to cut 1 lakh tonnes of carbon emissions yearly

Mint13 min ago

Ethanol blending: OMCs raise questions on Karnataka’s testing methodology

BusinessLine25 min ago

Premier Energies Q2 net profit rises 31% to ₹462.4 crore

BusinessLine36 min ago

SC says stopping vehicles, construction to prevent pollution ‘old, tried, failed tools’

BusinessLine38 min ago